NEXGEL to Report Second Quarter 2025 Financial Results on August 12th
NEXGEL (NASDAQ: NXGL), a provider of ultra-gentle hydrogel products for healthcare and consumer applications, will release its Q2 2025 financial results on August 12, 2025, after market close.
The company will host a conference call at 4:30 P.M. ET on the same day. Investors can join via phone at 1-800-274-8461 (U.S.) or 1-203-518-9814 (International). A replay will be available through August 26, 2025, and the webcast will be archived for 90 days.
NEXGEL (NASDAQ: NXGL), fornitore di prodotti in idrogel ultra-delicati per applicazioni sanitarie e di consumo, pubblicherà i suoi risultati finanziari del secondo trimestre 2025 il 12 agosto 2025, dopo la chiusura del mercato.
La società terrà una conference call alle 16:30 ET dello stesso giorno. Gli investitori potranno partecipare telefonicamente chiamando il numero 1-800-274-8461 (USA) o 1-203-518-9814 (internazionale). Una registrazione sarà disponibile fino al 26 agosto 2025 e la trasmissione web resterà archiviata per 90 giorni.
NEXGEL (NASDAQ: NXGL), proveedor de productos de hidrogel ultra-suaves para aplicaciones sanitarias y de consumo, publicará sus resultados financieros del segundo trimestre de 2025 el 12 de agosto de 2025, después del cierre del mercado.
La compañía realizará una llamada conferencia a las 4:30 P.M. ET ese mismo día. Los inversores pueden unirse por teléfono llamando al 1-800-274-8461 (EE.UU.) o 1-203-518-9814 (internacional). La repetición estará disponible hasta el 26 de agosto de 2025 y la transmisión web se archivará durante 90 días.
NEXGEL (NASDAQ: NXGL)은 의료 및 소비자용 초부드러운 하이드로겔 제품을 제공하는 기업으로, 2025년 2분기 재무 실적을 2025년 8월 12일 시장 마감 후 발표할 예정입니다.
같은 날 오후 4시 30분 ET에 컨퍼런스 콜을 진행합니다. 투자자들은 미국 내 1-800-274-8461 또는 국제 전화 1-203-518-9814로 전화 참여할 수 있습니다. 재방송은 2025년 8월 26일까지 제공되며, 웹캐스트는 90일간 아카이브됩니다.
NEXGEL (NASDAQ : NXGL), fournisseur de produits hydrogel ultra-doux pour les applications médicales et grand public, publiera ses résultats financiers du deuxième trimestre 2025 le 12 août 2025, après la clôture du marché.
La société tiendra une conférence téléphonique à 16h30 ET le même jour. Les investisseurs peuvent participer par téléphone au 1-800-274-8461 (États-Unis) ou au 1-203-518-9814 (international). La rediffusion sera disponible jusqu’au 26 août 2025 et le webcast sera archivé pendant 90 jours.
NEXGEL (NASDAQ: NXGL), Anbieter von ultra-sanften Hydrogel-Produkten für Gesundheits- und Verbraucheranwendungen, wird seine Finanzergebnisse für das zweite Quartal 2025 am 12. August 2025 nach Börsenschluss veröffentlichen.
Das Unternehmen wird am selben Tag um 16:30 Uhr ET eine Telefonkonferenz abhalten. Investoren können sich telefonisch unter 1-800-274-8461 (USA) oder 1-203-518-9814 (international) einwählen. Eine Aufzeichnung ist bis zum 26. August 2025 verfügbar, und das Webcast wird für 90 Tage archiviert.
- None.
- None.
Management will host a conference call at 4:30 P.M. ET on the same day
LANGHORNE, Pa., Aug. 06, 2025 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, today announced it will report its financial results for the second quarter 2025, after the market close on August 12, 2025. Following the release of its financial results, the Company will host a conference call at 4:30 P.M. ET on the same day.
Second Quarter 2025 Financial Results Conference Call
Date: August 12, 2025
Time: 4:30 P.M. ET
Live Call: 1-800-274-8461 (U.S. Toll Free) or 1-203-518-9814 (International)
Webcast: Events and Presentations
For interested individuals unable to join the conference call, a replay will be available through August 26, 2025, by dialing + 1-844-512-2921 (U.S. Toll Free) or + 1-412-317-6671 (International). Participants must use the following code to access the replay of the call: 11159686. An archived version of the webcast will also be available for 90 days.
About NEXGEL, INC.
NEXGEL is a leading provider of healthcare, beauty, and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogels. Based in Langhorne, Pa., the Company has developed and manufactured electron-beam, cross-linked hydrogels for over two decades. NEXGEL brands include Silverseal®, Hexagels®, Turfguard®, Kenkoderm® and Silly George®. Additionally, NEXGEL has strategic contract manufacturing relationships with leading consumer healthcare companies.
Investor Contact:
Valter Pinto, Managing Director
KCSA Strategic Communications
212.896.1254
Nexgel@KCSA.com
FAQ
When will NEXGEL (NXGL) report Q2 2025 earnings?
How can investors access NEXGEL's Q2 2025 earnings call?
What is the replay information for NEXGEL's Q2 2025 earnings call?
What does NEXGEL (NXGL) company do?
